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PHYSICO-CHEMICAL CHARACTERIZATION AND 
ANTIMICROBIAL ACTIVITY OF COPPER(II) COMPLEXES WITH 
2-AMINO AND 2-METHYLBENZIMIDAZOLE DERIVATIVES  
Sanja O. Podunavac-Kuzmanović, Siniša L. Markov and Ljiljana S. Vojinović 
Copper(II) chloride, in warm ethanolic solution, reacted with 2-amino and 2-methyl-
benzimidazole derivatives to give complexes of the formula CuL2Cl2·nH2O, where L=1-
benzyl-2-aminobenzimidazole, 1-(4-methylbenzyl)-2-aminobenzimidazole, 1-benzyl-2-methyl-
benzimidazole and 1-(4-methylbenzyl)-2-methylbenzimidazole; n=1 or 2). The complexes 
were characterized by elemental analysis of the metal, molar conductivity, magnetic sus-
ceptibility measurements and IR spectra. The molar conductivities of copper(II)com-
plexes in dimethyl formamide (DMF) corresponding to a 1:1 type of electrolytе indicate 
that in all the complexes one of the coordinated chloride ions has been replaced by DMF 
molecule. The room temperature effective magnetic moments and IR data of the complexes 
suggest that all Cu(II) complexes have a tetrahedral configuration, which is realized by 
participation of the pyridine nitrogen of two organic ligand molecules and two chloride 
anions. The antimicrobial activity of the ligands and their complexes against Pseudomonas 
aeruginosa, Bacillus sp., Staphylococcus aureus, Sarcina lutea and Saccharomyces ce-
revisiae was investigated. The effect of copper complexation on the ligand antimicrobial 
activity is discussed. 
KEYWORDS: Benzimidazole;  complexes; copper(II); physico-chemical 
  characterization; antimicrobial activity 
INTRODUCTION 
The antimicrobial activities of imidazoles and benzimidazoles have long been es-
tablished. Derivatives of these compounds are known for their antibacterial, antiviral and 
fungicidal activities (1-4). These groups of compounds are of wide interest because of their 
   
Dr. Sanja O. Podunavac-Kuzmanović, Assist. Prof., Faculty of Technology, 21000 Novi Sad, Bul. Cara Lazara 
1, Serbia and Montenegro; Dr. Siniša L. Markov, Assoc. Prof., Faculty of Technology, 21000 Novi Sad, Bul. 
Cara Lazara 1, Serbia and Montenegro; Ljiljana S. Vojinović, M.Sc., Ass., Department of Chemistry, Faculty 
of Sciences, 21000 Novi Sad, Trg Dositeja Obradovića 3, Serbia and Montenegro. 248 
diverse biological activity and clinical applications. This ring system is present in nume-
rous antiparasitic, antihelmintic and anti-inflammatory drugs. They are also inhibitors of 
photosynthesys, and some exhibit appreciable herbicidal activity (5-7). The success with 
these compounds stimulated the search for new biologically active derivatives. Many differ-
rent benzimidazoles have such activities as analgetics, anticarcinogens, antihistaminic, 
sedatives, etc (8-10). Various benzimidazoles are effective inhibitors of the growth of lac-
tobacilli, vaccinia virus, influenza virus and HIV-virus (11-12).  
The coordination chemistry of benzimidazole and its derivatives has received con-
siderable attention because of their biological significance and interesting spectral, mag-
netic and structural aspects. In view of previous observations (13-16) that the presence of 
metal ions considerably enhances the biological activity of organic molecules, we report 
the synthesis and study of copper(II) complexes with 2-amino and 2-methylbenzimida-
zole derivatives. The antimicrobial activity of these complexes have also been investiga-
ted and the effect of copper on the ligand antimicrobial activity is discussed. 
EXPERIMENTAL 
Reagents 
All chemicals used to prepare the complexes were of analytical reagent grade, com-
mercially available from different sources. 
Synthesis of complexes 
All the complexes were prepared following the same procedure. A solution of 5 
mmol of CuCl2 × 2H2O in 10 cm
3 of EtOH was added to a solution of 10 mmol of the li-
gand (1-benzyl-2-aminobenzimidazole (L
1), 1-(4-methylbenzyl)-2-aminobenzimidazole (L
2), 
1-benzyl-2-methylbenzimidazole (L
3), and 1-(4-methylbenzyl)-2-methylbenzimidazole (L
4)) 
in 10 cm
3 EtOH. The resulting mixture was refluxed for about 2 h and then cooled. The 
complexes were separated from the reaction mixture by filtration, washed with EtOH 
and dried in vacuo over CaCl2. The yield of the complexes varied in the range of 40-45%. 
Measurement methods 
The copper content was determined by a chelatometric titration with EDTA. Magne-
tic susceptibility measurements were made at room temperature using an MSB-MKI mag-
netic susceptibility balance (Sherwood Scientific Ltd., Cambridge, England). Molar con-
ductivies of freshly prepared 1 × 10
-3 mol dm
-3 solutions (DMF) were measured on a Jenway 
4010 conductivity meter. Infrared spectra (KBr pellets) were recorded on an Infrared 457 
Perkin-Elmer spectrophotometer.  
Antimicrobial investigations 
For these investigations the filter paper disc method was applied. Each of the inves-
tigated isolates of bacteria were seeded in the tubes with nutrient broth (NB). The seeded 249 
NB (1 cm
3) were homogenized in the tubes with 9 cm
3 of melted (45°C) nutrient agar (NA). 
The homogenous suspension was poured into Petri dishes. 
The discs of filter paper (diameter 5 mm) were ranged on cool. After cooling on the 
formed solid medium, 2 × 10
-5 dm
3 of the investigated compounds were placed with mi-
cropipette. After incubation for 24 hours in a thermostat at 25-27°C, inhibition (sterile) 
zone diameters (including disc) were measured and expressed in mm. Inhibition zone di-
ameter over 8 mm indicates the tested compound is active against bacteria under investi-
gation. Every test was done in three replications. 
The antimicrobial activities of the investigated compounds were tested against Pse-
udomonas aeruginosa, Bacillus sp., Staphylococcus aureus, Sarcina lutea and Saccha-
romyces cerevisiae. In parallel with antimicrobial investigations of Cu(II) complexes, all 
ligands were tested too, as well as the pure solvent. The concentration of each solution was 
5 × 10
-2 mol dm
-3. Commercial DMF was employed to dissolve the tested samples. 
RESULTS AND DISCUSSION 
The elemental analysis of complexes, magnetic moments and molar conductivity 
data are summarized in Table 1. The complexes were synthesized in the reaction of warm 
ethanolic solution of the CuCl2 × 2H2O with L
1, L
2,
 L
3 or L
4 in a mole ratio 1 : 2. It should 
be noticed that the reaction of the copper ions yielded bis(ligand) complexes.  
All the complexes are insoluble in most common organic solvents. They are highly 
soluble in DMF and dimethyl sulphoxide (DMSO), somewhat less soluble in MeOH and 
EtOH.  
Table 1. Some physical characteristics and analytical data of the complexes 
Complex Colour  µeff (µB)  λM *  Metal ( %) 
Found (Calcd.) 
Cu(L
1)2Cl2 × H2O  yellow-green 1.83  84.6  10.47  (10.62) 
Cu(L
2)2Cl2 × 2H2O  yellow-green 1.81  80.2  9.40  (9.86) 
Cu(L
3)2Cl2 × H2O  brown 1.79  76.2  10.29  (10.65) 
Cu(L
4)2Cl2 × 2H2O  dark-red 1.89 74.7  9.95  (9.89) 
* In DMF, 1 mmol dm
-3 solution at 25
o C; in S cm
2 mol
-1 
The molar conductivities of copper(II) complexes in DMFsolutions fall in the range 
of 74-85 Scm
2mol
-1 corresponding to a 1:1 type of electrolyte (65-90 Scm
2mol
-1) (17). 
This indicates that in DMF solutions one of the coordinated chloride ions has been re-
placed by solvent molecule. 
Magnetic properties 
The room temperature effective magnetic moments of the copper(II) complexes are 
in the range of 1.73-2.20µB, which corresponds to one unpaired electron typical of the mo-
nomeric d
9 system (18). 250 
Infrared spectra 
The band appearing at about 1550 cm
-1, for all the ligands, may be assigned to the 
ν (C=N) vibrations (19,20). Substituted phenyl group shows ring vibrations at 1485 and 
740 cm
-1. The IR of the ligands L
1 and L
2 exhibit the bands at 3450-3330 cm
-1 and ca. 
1650 cm
-1, assigned to ν (NH2) and δ (NH2) of the benzimidazole ring, respectively (20). The 
IR of the investigated complexes are similar to those of the corresponding ligands. 
An upward shift (5-15 cm
-1) of ν(C=N) in the IR spectra of the complexes as compa-
red to theirs values in the free ligands, suggests coordination through pyridine nitrogen of 
benzimidazoles. The Cu(L
1)2Cl2 × H2O and Cu(L
2)2 Cl2 × 2H2O bands due to ν (NH2) and 
δ (NH2) are shifted to lower frequency. These shifts may be indicative of hydrogen bonding 
formed between − NH2 group from the ligand and water molecule. The other bands in 
the spectrum of each complex are similar to those in the corresponding ligand spectrum 
except for slight shifts in their positions and changes in their intensities due to coordina-
tion. 
The presented results (molar conductivities, magnetic moments and IR spectra) suggest 
that all the copper(II) complexes have a tetrahedral configuration, which is realized by 
coordination of the two organic ligand molecules through the pyridine nitrogen and chloride 
anions or water molecules. 
Antimicrobial investigationsin 
All the ligands and their copper(II) complexes were screened for their antimicrobial 
activities against Pseudomonas aeruginosa, Bacillus sp., Staphylococcus aureus, Sarcina 
lutea and Saccharomyces cerevisiae. The relevant data are presented in Table 2. 
Table 2. Results of in vitro antimicrobial activity of  the tested compounds 
Compound  P. aeruginosa  B. species  S. aureus  S. lutea  S. cerevisiae 
L
1  + ++  ++  ++  ∅ 
Cu(L
1)2Cl2 × H2O  +++ +++ +  +++  ∅ 
L
2  ++ ++++  ++++  ++++  +++ 
Cu(L
2)2Cl2 × 2H2O  +++ +++  +++  +++  ++ 
L
3  + +  +  ++  ∅ 
Cu(L
3)2Cl2 × H2O  +++ +++ +  +++  ∅ 
L
4  ++ +++  +++  +++  ∅ 
Cu(L
4)2Cl2 × 2H2O  +++ +++  ++  ++  ∅ 
Key to simbols: 
Very highly active ++++, Highly active +++, Moderately active ++, Slightly active +, Inactive ∅  
It is evident that all the ligands and their copper(II) complexes are active against 
gram-positive and gram-negative bacteria. Only compound L
2 and its complex showed 
activity against all of the standard test organisms, including yeast and gram-positive and 
gram-negative bacteria. The basic antimicrobial activity of 2-amino and 2-methylbenzimida-
zole derivatives is produced by the presence of benzimidazole ring as a known pharma-
cophore. Antimicrobial results shows that amino group as substituent at the position 2 in-251 
creased the general antimicrobial activity of the relevant benzimidazoles (21). If the benz-
imidazole nucleus was replaced with a substituted benzyl group at the N1 atom, the antimic-
robial activity was increased, particularly in the presence of meta or para substituents 
(21). The proof of this is that the most active compound was 1-(4-methylbenzyl)-2-amino-
benzimidazole (L
2), as well as its copper(II) complex (Table 2). In the case of Saccha-
romyces cerevisiae 4-methyl substituted benzyl group at the N1 atom highly increased 
the general antimicrobial activity of the relevant tested benzimidazoles. On the other 
hand, its Cu(II) complex showed medium activity. The other tested ligands and complexes 
had no activity against yeast Saccharomyces cerevisiae. Comparing the activities of the 
tested ligands and their complexes, it was found that some of the complexes were more 
active than starting ligands. The copper(II) complexes were more active than ligands against 
Pseudomonas aeruginosa, but less active than the ligand itself against Staphylococcus 
aureus and Sarcina lutea (except for Cu(L
1)2Cl2 × H2O and complexes activity, substitu-
ted ligands and copper moiety may play a role in the antimicrobial activity. 
CONCLUSIONS 
With copper(II) 2-amino- and 2-methylbenzimidazole formed complexes of the ge-
neral formula CuL2Cl2 ×  nH2O, where L=1-benzyl-2-aminobenzimidazole, 1-(4-methylben-
zyl)-2-aminobenzimidazole, 1-benzyl-2-methylbenzimidazole and 1-(4-methylbenzyl)-2-
methylbenzimidazole; n=1 or 2). The molar conductivities of copper(II) complexes in DMF 
solutions are in the range corresponding to a 1:1 type of electrolyte. This indicates that in 
all the complexes one of the coordinated chloride ions has been replaced by DMF 
molecule. All the complexes are tetrahedral, the configuration being realized by coordi-
nation of the pyridine nitrogen of the two organic ligand molecules and two chloride 
anions. The results of antibacterial investigations indicate that all the ligands and their 
copper(II) complexes are active against gram-positive and gram-negative bacteria. Only 
compound L
2 and its complex showed activity against all of the standard test organisms, 
including yeast and gram-positive and gram-negative bacteria. The most active compound 
was 1-(4-methylbenzyl)-2-aminobenzimidazole (L
2), as well as its copper(II) complex. Com-
paring the activities of the tested ligands and their complexes, it was found that some of the 
complexes were more active than the starting ligands. The copper(II) complexes were more 
active than ligands against Pseudomonas aeruginosa, but less active than the ligand against 
Staphylococcus aureus and Sarcina lutea (except Cu(L
1)2Cl2 × H2O and Cu(L
3)2Cl2 × H2O). 
Consideration of the structural formula of the compounds that exhibit antimicrobial acti-
vity, substituted ligands and copper moiety may play a role in the antimicrobial activity. 
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ФИЗИЧКО-ХЕМИЈСКА КАРАКТЕРИЗАЦИЈА И АНТИМИКРОБНА 
АКТИВНОСТ БАКАР(II) КОМПЛЕКСА СА 2-АМИНО И 2-МЕТИЛ 
ДЕРИВАТИМА БЕНЗИМИДАЗОЛА 
Сања О. Подунавац-Кузмановић, Синиша Л. Марков и Љиљана С. Војиновић 
Хлорид бакра(II) у топлим етанолним растворима реагује са 2-амино и 2-метил 
дериватима бензимидазола дајући комплексе типа CuL2Cl2 × nH2O (L=1-бензил-2-
аминобензимидазол, 1-(4-метилбензил)-2-аминобензимидазол, 1-бензил-2-метилбенз-
имидазол и 1-(4-метилбензил)-2-метилбензимидазол; n=1 или 2). Комплекси су ока-
рактерисани елементарном анализом (метал), магнетним и кондуктометријским ме-
рењима и IR спектрима. На основу вредности моларних проводљивости комплекса 
бакра(II) у ДМФ раствору карактеристичних за комплексе електролита типа 1:1 из-
води се закључак да је један од координованих хлоридних анјона замењен молеку-
лом  растварача.  На  основу  вредности  магнетних  момената  и IR спектара  изо-
лованих комплекса бакра(II) може се претпоставити да испитивани комплекси имају 254 
тетраедарску структуру која се реализује монодентатном координацијом два моле-
кула лиганда преко пиридинског атома азота и координацијом два хлоридна јона. 
Испитана је антимикробна активност лиганада као и њихових комплекса на Pseu-
domonas aeruginosa, Bacillus sp., Staphylococcus aureus, Sarcina lutea и Saccharo-
myces cerevisiae. Продискутован је утицај комплексирања бакра на антимикробну 
активност лиганада. 
Received 13 March 2004 
Accepted 20 May 2004 